Safety

back

References

  • 1.Bayer internal study report - data on file.
  • 2. Bayer internal study report - data on file.
  • 3. Bayer internal study report - data on file.
  • 4. Bayer internal study report - data on file.
  • 5. Bayer internal study report - data on file.
  • 6. Bayer internal study report ID 27427.
  • 7. Müller RS and Bernd S. Pradofloxacin in the treatment of canine deep pyoderma: a multicentred, blinded, randomized parallel trial. Veterinary Dermatology 2007; 18: 144–151.
  • 8. Restrepo C et al. Evaluation of the Clinical Efficacy of Pradofloxacin Tablets for the Treatment of Canine Pyoderma. J Am Anim Hosp Assoc 2010; 46: 301-311.
  • 9. Bayer internal study report - data on file.
  • 10. Bayer internal study report - data on file.
  • 11. Bayer internal study report - data on file.
  • 12. Bayer internal study report - data on file.
  • 13. Bayer internal study report - data on file.
  • 14. Bayer internal study report - data on file.
  • 15. Bayer internal study report - data on file.
  • 16. Bayer internal study report - data on file.
  • 17. Bayer internal study report - data on file.
  • 18. Bayer internal study report - data on file.
  • 19. Bayer internal study report - data on file.
  • 20. Bayer internal study report - data on file.
  • 21. Bayer internal study report - data on file.
  • 22. Bayer internal study report - data on file.
  • 23. Bayer internal study report - data on file.
  • 24. Bayer internal study report - data on file.
  • 25. Gelatt KN, et al.  Enrofloxacin-associated retinal degeneration in cats. Vet Ophthalmol 2001; 4: 99-106.
  • 26. Wiebe V and Hamilton P. Fluoroquinolone-induced retinal degeneration in cats. JAVMA 2002; 221(11): 1568-71.
  • 27. Abrams-Ogg A et al. Blindness attributed to enrofloxacin therapy in a previously reported case of a cat with acromegaly treated by cryohypophysectomy. Can Vet J (2002); 43: 53-54.
  • 28. Ford MM et al. Ocular and systemic manifestations after oral administration of a high dose of enrofloxacin in cats. Am J Vet Res 2007; 68: 190-202.
  • 29. Bayer internal pharmacological-toxicological expert report ID 33280.
  • 30. Ramirez C et al. Molecular genetic basis for fluoroquinolone-induced retinal degeneration in cats. Pharmacogenetics and Genomics 2011; 21: 66-75.
  • 31. Messias A et al. Retinal safety of a new fluoroquinolone, pradofloxacin, in cats: assessment with eletroretinography. Doc Ophthalmol 2008; 116: 177-191.
  • 32. Bayer internal study report - data on file.
  • 33. Bayer internal study report - data on file.
  • 34. Bayer internal study report - data on file.
  • 35. Bayer internal study report - data on file.
  • 36. Bayer internal study number 151.594.
  • 37. Bayer internal study report - data on file.
  • 38. Bayer internal study report - data on file.
  • 39. Bayer internal study report - data on file.
  • 40. Bayer internal study report - data on file.
Rate this page

latest documents

3rd row with links